Your request to link to rcsb for ADAM17

• 1ZXC: crystal structure of catalytic domain of tnf-alpha converting enzyme (tace) with inhibitor (10.1016/J.BMCL.2005.06.072 )
• 2A8H: crystal structure of catalytic domain of tace with thiomorpholine sulfonamide hydroxamate inhibitor (10.1016/J.BMCL.2005.12.020 )
• 2DDF: crystal structure of tace in complex with tapi-2 (10.1093/PROTEIN/GZJ014 )
• 2FV5: crystal structure of tace in complex with ik682 (10.1016/J.ABB.2006.03.034 )
• 2FV9: crystal structure of tace in complex with jmv 390-1 01-feb-17 2fv9 1 title (10.1093/PROTEIN/GZJ014 )
• 2I47: crystal structure of catalytic domain of tace with inhibitor (10.1016/J.BMCL.2006.10.004 )
• 2OI0: crystal structure analysis 0f the tnf-a coverting enzyme (tace) in complexed with aryl-sulfonamide (10.1016/J.BMCL.2007.01.064 )
• 3B92: novel thio-based tace inhibitors part 2: rational design, synthesis and sar of thiol-contaning aryl sufones (10.1016/J.BMCL.2007.11.014 )
• 3CKI: crystal structure of the tace-n-timp-3 complex (10.1016/J.JMB.2008.06.088 )
• 3E8R: crystal structure of catalytic domain of tace with hydroxamate inhibitor (10.1016/J.BMCL.2008.09.045 )
• 3EDZ: crystal structure of catalytic domain of tace with hydroxamate inhibitor (10.1016/J.BMCL.2008.09.045 )
• 3EWJ: crystal structure of catalytic domain of tace with carboxylate inhibitor (10.1016/J.BMCL.2008.11.034 )
• 3G42: crystal structure of tace with tryptophan sulfonamide derivative inhibitor (10.1016/J.BMC.2009.04.033 )
• 3KMC: crystal structure of catalytic domain of tace with tartrate-based inhibitor (10.1016/J.BMCL.2009.12.004 )
• 3KME: crystal structure of catalytic domain of tace with phenyl- pyrrolidinyl-tartrate inhibitor (10.1016/J.BMCL.2009.12.004 )
• 3L0T: crystal structure of catalytic domain of tace with hydantoin inhibitor (10.1016/J.BMCL.2010.01.148 )
• 3L0V: crystal structure of catalytic domain of tace with the first hydantoin inhibitor occupying the s1' pocket (10.1016/J.BMCL.2010.01.148 )
• 3LE9: crystal structure of the catalytic domain of tace with indazolinone- phenyl-hydantoin inhibitor (10.1016/J.BMCL.2010.06.134 )
• 3LEA: crystal structure of the catalytic domain of tace with isoindolinone- biphenyl-hydantoin inhibitor (10.1016/J.BMCL.2010.06.134 )
• 3LGP: crystal structure of catalytic domain of tace with benzimidazolyl- thienyl-tartrate based inhibitor (10.1016/J.BMCL.2010.06.104 )
• 3O64: crystal structure of catalytic domain of tace with 2-(2-aminothiazol- 4-yl)pyrrolidine-based tartrate diamides (10.1016/J.BMCL.2011.01.002 )